1. Concomitant initiation of combination therapy with macitentan and tadalafil in pulmonary arterial hypertension (PAH) patients with comorbidities: real-world data from OPUS and OrPHeUS. (3rd October 2022) Authors: Channick, R; Chin, K M; Kim, N H; Ong, R; Turricchia, S; Mitchell, L; McLaughlin, V V Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment effect of selexipag on time to disease progression when initiated early in pulmonary arterial hypertension (PAH) patients: GRIPHON and TRITON pooled analysis. (14th October 2021) Authors: Coghlan, G J; Gaine, S; Channick, R N; Chin, K M; Du Roure, C; Gibbs, J S R; Hoeper, M M; Lang, I M; Mathai, S C; McLaughlin, V V; Mitchell, L; Simonneau, G; Sitbon, O; Tapson, V; Galie, N Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗